SM2-55003-68445
3 vaccinations
1 coded response
25 check-ins
1 free-text entry
0 call cases
- Sex
- Male
- Age at first dose
- 05-11
- ZIP prefix
- 240 / VA
- Registered
- 2021-11-05
- Relationship
- Child or adolescent in my care
- Guardian
- LYC-24361-50494
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-11-05
Registered in v-safe
-
2021-11-05
Dose 1 — Pfizer-BioNTech
- 2021-11-05
-
2021-11-07
Health check-in — days 1–6 daily, dose 1, dependentFeeling: Good · Site: Pain · NoneAdult check-in
- 2021-11-08
- 2021-11-09
- 2021-11-14
- 2021-11-19
- 2021-11-26
-
2021-12-01
Dose 2 — Pfizer-BioNTech
- 2021-12-05
- 2021-12-06
- 2021-12-07
- 2021-12-08
- 2021-12-17
- 2021-12-22
- 2021-12-29
- 2022-01-05
- 2022-01-13
- 2022-06-04
-
2022-07-18
Dose 3 — Pfizer-BioNTech
- 2022-07-18
-
2022-07-19
Health check-in — days 1–6 daily, dose 3, dependentFeeling: Good · Site: Pain · NoneAdult check-in
- 2022-07-20
- 2022-07-21
-
2022-08-09
Survey response — day 21, dose 3, dependentMedDRA: Nasal congestion, Sneezing — Feeling: FairFree text: Stuffy nose, sneezing.MedDRA releases: 2024-11 · check-in free text available
- 2022-08-16
- 2022-09-03
- 2023-01-20
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-11-05 | Pfizer-BioNTech | No |
| 2 | 2021-12-01 | Pfizer-BioNTech | No |
| 3 | 2022-07-18 | Pfizer-BioNTech | No |
Free text
Release 12 — day 21, dose 3, dependent
Symptoms: Stuffy nose, sneezing.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Nasal congestion | · | · | ✓ |
| SD | Sneezing | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release